光动力疗法
原卟啉IX
光敏剂
体内
医学
金黄色葡萄球菌
抗生素
全身给药
微生物学
药理学
化学
生物
光化学
细菌
有机化学
生物技术
遗传学
作者
Kuniyuki Morimoto,Toshiyuki Ozawa,Kunio Awazu,Nobuhisa Ito,Norihiro Honda,Sohkichi Matsumoto,Daisuke Tsuruta
出处
期刊:PLOS ONE
[Public Library of Science]
日期:2014-08-20
卷期号:9 (8): e105173-e105173
被引量:69
标识
DOI:10.1371/journal.pone.0105173
摘要
Bacterial resistance to antibiotics has become a worldwide problem. One potential alternative for bacterial control is photodynamic therapy. 5-aminolevulinic acid is a natural precursor of the photosensitizer protoporphyrin IX. Relatively little is known about the antibacterial efficacy of photodynamic therapy using the systemic administration of 5-aminolevulinic acid; a few reports have shown that 5-aminolevulinic acid exerts photodynamic effects on methicillin-resistant Staphylococcus aureus (MRSA) in vitro. In this study, we evaluated the effectiveness of photodynamic therapy using 5-aminolevulinic acid and a 410-nm wavelength light-emitting diode in vitro and in vivo for the treatment of MRSA. We found that 5-aminolevulinic acid photodynamic therapy with the light-emitting diode had an in-vitro bactericidal effect on MRSA. In vivo, protoporphyrin IX successfully accumulated in MRSA on ulcer surfaces after intraperitoneal administration of 5-aminolevulinic acid to mice. Furthermore, 5-aminolevulinic acid photodynamic therapy accelerated wound healing and decreased bacterial counts on ulcer surfaces; in contrast, vancomycin treatment did not accelerate wound healing. Our findings indicate that 5-aminolevulinic acid photodynamic therapy may be a new treatment option for MRSA-infected wounds.
科研通智能强力驱动
Strongly Powered by AbleSci AI